Lynn Stockwell - Jan 7, 2025 Form 3 Insider Report for Drugs Made In America Acquisition Corp. (DMAA)

Role: Chief Executive Officer and Executive Chair of the Board, Director, 10%+ Owner
Signature: /s/ Lynn Stockwell
Stock symbol: DMAA
Transactions as of: Jan 7, 2025
Transactions value $: $0
Form type: 3
Date filed: 1/10/2025, 07:45 AM
Previous filing: Jun 10, 2024
Next filing: Feb 4, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	DMAA	Ordinary Shares						9.86M	Jan 7, 2025	See Footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of shares owned by Drugs Made In America Acquisition LLC (the "sponsor"). Lynn Stockwood is the managing member of the sponsor and has voting and dispositive power over the shares owned by the sponsor. Ms. Stockwell disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest she may have therein, directly or indirectly.

Remarks:

Chief Executive Officer and Executive Chair of the Board